SLNO — Soleno Therapeutics, Inc.

SLNOSoleno Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · soleno.life

53.01USD0.00%Mkt Cap: 2.76B USDP/E: 27.47Last update: 2026-05-18

Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap2.76B USD

Enterprise Value2.56B USD

Revenue (TTM)285.01M USD

Gross Profit187.71M USD

Net Income (TTM)20.89M USD

Revenue/Share5.450 USD

Last Price53.01 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees182

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)27.47

P/E (Forward)-23.35

PEG—

EV/EBITDA27.99

EV/Revenue8.99

P/S9.69

P/B6.16

EPS (TTM)1.93

EPS (Forward)-2.27

52W Range

29.4339% of range90.32

52W High90.32 USD

52W Low29.43 USD

Profitability

Gross Margin98.58%

Oper. Margin33.57%

EBITDA Margin32.11%

Profit Margin10.97%

ROE4.64%

ROA3.71%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF46.80M USD

CapEx (TTM)73.00K USD

FCF Margin32.16%

FCF Yield3.32%

Net Debt-201.32M USD

Net Debt/EBITDA-2.20

Balance Sheet

Debt/Equity0.12

Current Ratio5.62

Quick Ratio5.21

Book Value/Sh8.609 USD

Cash/Share4.904 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateOct 6, 2017

Splits

Last Split1:15

Split DateAug 26, 2022

Analyst Consensus

Rating3.0 (Hold)

Target (Mean)53.00 USD

Target Range53.00 USD – 53.00 USD

# Analysts5

Ownership

Shares Out.52.12M

Float51.46M

Insiders1.31%

Institutions111.53%

Short Interest

Short Ratio1.0d

Short % Float17.89%

Short % Out.12.52%

Shares Short6.53M

Short (prev mo.)8.45M

Technical

SMA 5045.78 (+15.8%)

SMA 20051.16 (+3.6%)

Beta-2.22

S&P 52W Chg28.31%

Avg Vol (30d)3.35M

Avg Vol (10d)1.80M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—